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Laminin-guided highly efficient 
endothelial commitment from 
human pluripotent stem cells
Ryo Ohta1,*, Akira Niwa1,*, Yukimasa Taniguchi2, Naoya M. Suzuki1, Junko Toga2, 
Emiko Yagi2, Norikazu Saiki1, Yoko Nishinaka-Arai1, Chihiro Okada3,4, Akira Watanabe3, 
Tatsutoshi Nakahata1, Kiyotoshi Sekiguchi2 & Megumu K. Saito1
Obtaining highly purified differentiated cells via directed differentiation from human pluripotent stem 
cells (hPSCs) is an essential step for their clinical application. Among the various conditions that should 
be optimized, the precise role and contribution of the extracellular matrix (ECM) during differentiation 
are relatively unclear. Here, using a short fragment of laminin 411 (LM411-E8), an ECM predominantly 
expressed in the vascular endothelial basement membrane, we demonstrate that the directed 
switching of defined ECMs robustly yields highly-purified (>95%) endothelial progenitor cells (PSC-
EPCs) without cell sorting from hPSCs in an integrin-laminin axis-dependent manner. Single-cell RNA-
seq analysis revealed that LM411-E8 resolved intercellular transcriptional heterogeneity and escorted 
the progenitor cells to the appropriate differentiation pathway. The PSC-EPCs gave rise to functional 
endothelial cells both in vivo and in vitro. We therefore propose that sequential switching of defined 
matrices is an important concept for guiding cells towards desired fate.
The ECM forms the basal membrane to which it anchor cells in vivo, thereby regulating cellular survival, prolifera-
tion and differentiation by transducing various signals via cell surface receptors1. Because of these properties, var-
ious ECM coatings have been used for both embryonic tissue- and PSC-derived differentiation cultures. However, 
the selection and combination of ECMs for in vitro culture are determined rather empirically compared with other 
parameters, such as the cytokine levels and medium, yet must be well defined for directed differentiation from PSCs. 
Although optimizing the ECM coating at each in vitro stage is considered important for directed differentiation, there 
is little understanding of how the selection and switching of culture matrices determines the fate of progenitor cells.
Vascular endothelial cells (ECs) differentiated from PSCs have potential benefits for regenerative medicine of 
vascular diseases as well as in vitro disease modeling with patient-derived induced pluripotent stem cells (iPSCs), 
and a number of protocols for deriving ECs have been developed2–4. In the present work, we show the optimi-
zation of orderly endothelial cell development could be achieved by switching matrices during differentiation.
Result
Successful endothelial cell induction in conventional 2D method. Since a monolayer and feed-
er-free differentiation system suitable for exploring the role and effect of coating matrices, we first applied our 
feeder- and serum-free monolayer hematopoietic cell differentiation system on Matrigel5,6 for selective endothe-
lial differentiation. This system develops VE-cadherin+ ECs concomitantly with hematopoietic cells from mes-
odermal progenitors5 (Supplementary Fig. 1a). Indeed, sequential cytokine switching successfully produced 
KDR+CD34+VE-cadherin+ PSC-EPCs (Supplementary Fig. 1b). Subsequent culture induced functional PSC-
derived ECs that expressed the endothelial marker CD31 and incorporated acetyl-low-density-lipoprotein 
(Ac-LDL) on day 10 (Supplementary Fig. 1c), indicating successful differentiation into functional ECs. However, 
the efficiency for inducing PSC-EPCs was very low (approximately 10%) despite successful initial commitment 
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to the mesodermal lineage (> 80% of cells were KDR+ on day 3, Supplementary Fig. 1d) and subsequent VEGF 
stimulation.
Discovery of coating condition appropriate for endothelial differentiation from mesodermal 
progenitors. Since the vast majority of day 3 cells were positive for KDR, we next explored more appropri-
ate conditions for their differentiation to endothelial lineage. We investigated various matrices onto which day 
3 cells were plated and cultured for an additional 4 days in the presence of VEGF. As a result, we found that the 
non-coated and laminin 411 (LM411)-coated conditions reproducibly induced endothelial commitment with 
higher purity than other conditions (Fig. 1a–c, Supplementary Fig. 2). Of particular note, LM411 reproducibly 
presented a higher yield than the non-coated condition while maintaining comparable purity (Supplementary 
Fig. 3). The ECs derived from PSC-EPCs on LM411 possessed the capacities for Ac-LDL uptake and endothelial 
tube formation (Fig. 1d,e). Interestingly, matrices suitable for undifferentiated human PSCs such as Matrigel and 
laminin 511(LM511)7 showed relatively low purity (Fig. 1b), while LM411 could not support PSCs (data not 
shown). Taken together, these results demonstrated that LM411 acts as a suitable matrix for producing highly 
purified PSC-EPCs from mesodermal progenitors in day3 cells.
The LM411-E8 fragment improved the endothelial cell yield and angiogenesis capacity. 
Laminins are a common ECM component and responsible for various forms of cell-to-basement membrane 
adhesion7. There are 15 laminin isoforms in mammals including humans, among which laminin 411 (LM411) is 
the major isoform that lines the basal membrane of endothelial cells in capillary vessels and binds mainly to the 
cell surface transmembrane receptors integrin α 6β 1 and α 7X1β 18. Based on the observation that laminins bind to 
integrins at their C-terminal region, we generated E8 fragments, which is the truncated form of the laminins that 
represent the C-terminal region9. E8 fragments retain full binding activity toward integrins but lack binding activ-
ities to other components, such as heparin/heparan sulfate. E8 fragments of LM511 and LM332 (LM511-E8 and 
LM332-E8, respectively) possess greater activity of PSC adhesion than their intact forms10. Accordingly, we next 
Figure 1. Differentiation of PSC-EPCs from human pluripotent stem cells using directed matrix switching. 
(a) Schematic outline of endothelial cell differentiation. (b) Purity of PSC-EPCs on day 7. Data are presented as 
the mean ± SEM (n = 3) and were statistically analyzed using ANOVA test. (c) Representative flow cytometry 
plots of cells (day 7) on LM411 (KhES-1). (d) Tube formation assay of PSC-ECs induced on LM411. Scale bar: 
200 μ m. (e) Ac-LDL-uptake and CD31 expression of PSC-ECs induced on LM411. Scale bar: 10 μ m.
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explored whether or not the LM411-E8 fragment (LM411E8) can improve the yield of PSC-EPCs (Supplementary 
Fig. 4a). Undifferentiated PSCs hardly adhered onto LM411-E8 coated dish, as with full-length LM411 (data not 
shown), but LM411-E8 showed significantly stronger adhesive properties with respect to day3 cells than did 
LM411 (Fig. 2a). In particular, cell adhesion increased in a dose-dependent manner, even with a higher cellular 
density (Fig. 2b), and the purity of PSC-EPCs on LM411-E8 continued to exceed 95%, which exceeded that on 
LM411, resulting in a significant increase in the cell number of PSC-EPCs (Fig. 2c,d, hereafter, mesodermal 
progenitors fitted to LM411-E8-mediated endothelial differentiation were referred to PSC-MPCs). Endothelial 
surface markers such as CD14611, CD14312, Tie-213 and EphB414 were expressed on day 9 cells, while a pluripo-
tent marker Tra-1-60 was scarcely expressed (Supplementary Fig. 4b). Notably, PSC-EPCs derived on LM411-E8 
yielded the endothelial cells that form longer and more branched tubes than those on LM411 (Fig. 2e–g, 
Supplementary Fig. 4c). In addition, PSC-EPCs on LM411-E8 also internalized Ac-LDL (Supplementary Fig. 4d).
In order to further evaluate the characteristics of PSC-EPCs on LM411-E8, we performed RNA-seq analysis 
of PSC-EPCs under several coating conditions. The transcriptional profiles of PSC-EPCs were closer to those of 
the primary endothelial cell-derived cell lines, such as HUVECs and HAECs, than parental ESCs (Supplementary 
Figure 2. Functional properties of LM411-E8 for endothelial differentiation. (a) Cell adhesion assay of 
day 3 PSC-MPCs (KhES-1). Data are presented as the mean ± SEM (n = 3) and were statistically analyzed 
using Student’s t-test. Representative results of at least three independent experiments are shown. (b) Effect 
of coating density of LM411-E8 on the adhesion of PSC-MPCs derived from KhES-1. (c) Representative flow 
cytometry plots of cells (day 7) on LM411-E8. (d) Estimated yield of PSC-EPCs from one PSC-MPC. Data are 
presented as the mean ± SEM (n = 3) and were statistically analyzed using Student’s t-test. Representative results 
of at least three independent experiments are shown. (e–g) Evaluation of angiogenesis properties of PSC-ECs 
differentiated on non-coated dishes, LM411 or LM411-E8. (e) Representative images of tube-like structures 
formed by PSC-ECs derived from KhES-1. Scale bar: 500 μ m. (f) Total tube length per well. Data are presented 
as the mean ± SEM (n = 3) and were statistically analyzed using Student’s t-test. Representative results of at least 
two independent experiments are shown. (g) Branching points per well. Data are presented as the mean ± SEM 
(n = 3) and were statistically analyzed using Student’s t-test. Representative results of at least two independent 
experiments are shown. (h) PSC-MPC adhesion was abrogated by LM411-E8 (EQ). Data are presented as the 
mean ± SEM (n = 3) and were statistically analyzed using Student’s t-test. Representative results of at least two 
independent experiments are shown.
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Fig. 5a,b). As for specific gene expressions, some endothelial development-associated genes, such as LMO2, 
NOTCH1, HEY2, DLL4 and NRP111,15,16, are upregulated, while function-associated genes, such as IL8, IL6, IL18, 
NFKB1, EDN1 and CAV117–19, are downregulated in PSC-EPCs. However, representative common endothelial 
characteristic markers, such as CDH5, PECAM1 and MCAM, are expressed both on PSC-EPCs and primary 
ECs at comparable levels (Supplementary Fig. 5d). Moreover, the PSC-EPCs on LM411-E8 belonged to a cluster 
distinct from those on the full-length LM411/non-coating dish (Supplementary Fig. 5b), and a gene ontology 
analysis revealed that PSC-EPCs on LM411-E8 express lines of genes associated with vasculature development 
and angiogenesis at higher levels compared to those derived under other conditions (Supplementary Fig. 5c). 
Taken together, those data support the contribution of LM411-E8 to the endothelial induction in our system both 
in function, yield and purity.
Initial adhesion of PSC-MPCs to LM411-E8 is dependent on integrin α6β1. We next explored 
the mechanisms underlying endothelial differentiation on LM411-E8. We first investigated whether the initial 
adhesion of PSC-MPCs onto LM411-E8 is dependent on the integrin-laminin axis, as adhesion to ligands other 
than integrins is usually abrogated in laminin-E8 fragments. For this purpose, we pre-treated PSC-MPCs with 
specific blocking antibodies against the α 6 or β 1 integrin subunits, both of which are expressed on PSC-MPCs 
(Supplementary Fig. 6a). Consequently, the adhered cells were significantly decreased to a level comparable to 
that observed under the non-coating condition (Supplementary Fig. 6b). Furthermore, we evaluated the degree 
of cell adhesion onto a mutant fragment of LM411-E8 (LM411-E8(EQ)), in which the Glu residue (E) in the 
C-terminal tail region of the γ 1 chain of LM411-E8 was replaced with Gln (Q) to nullify integrin binding activity 
(Supplementary Fig. 6c). Notably, the adhesion of PSC-MPCs on LM411-E8 (EQ) was significantly decreased and 
comparable to that seen in the uncoated dishes (Fig. 2h). Overall, these data indicate that surface integrin family 
proteins, especially integrin α 6β 1, mediate the initial adhesion of PSC-MPCs onto LM411-E8.
LM411-E8 guides PSC-MPCs into endothelial lineage in VEGF-dependent manner. We 
next investigated whether LM411-E8 possess the ability to facilitate the endothelial differentiation of adhered 
PSC-MPCs. For this purpose, we carried out a double-switching assay (Fig. 3a) in which PSC-MPCs once 
adhered onto LM411-E8 were harvested again and subsequently seeded onto Matrigel, LM511-E8 or LM411-E8. 
LM411-E8 increased the purity of PSC-EPCs compared to Matrigel or LM511-E8 (Fig. 3b,c), indicating that 
LM411-E8 not only selects cells via integrin-dependent adhesion but also facilitates the endothelial differentia-
tion of adhered progenitor cells. In the absence of VEGF, however, few PSC-EPCs were induced, even under the 
LM411-E8-coated condition (Supplementary Fig. 7).
Single-cell RNA-seq analysis reveals involvement of Rho pathway in the endothelial differen-
tiation of cells on LM411-E8. In order to investigate the effects of the matrices on endothelial differenti-
ation at the single cell level, we next performed single-cell RNA-seq analysis. We plated PSC-MPCs onto fresh 
Matrigel- or LM411-E8-coated dishes and sampled single cells at different time points (Fig. 4a, Supplementary 
Fig. 8). Consequently, we detected a comparable number of genes in each cell (Supplementary Fig. 9a,b). Principal 
component analysis (PCA) depicted a seamless transition of the transcriptional profiles during differentiation 
at single-cell resolution (Fig. 4b). In this panel, we could putatively classify each sample into six differentia-
tion stages: A (pluripotent stem cells), B (early mesodermal progenitors), C (mesoderm progenitors), D (early 
endothelial progenitors), E (intermediate endothelial progenitors), F (late endothelial progenitors) and others 
(Fig. 4b). According to this classification, expression of literature-based representative genes related to mesoderm 
and endothelial differentiation, such as KDR (NM_002253), CDH5 (NM_001795) and PECAM1 (NM_000442), 
were confirmed to be orderly up-regulated while a pluripotent stem cell marker ZFP42 (REX1, NM_174900) was 
down-regulated (Fig. 4c). Notably, the profiles of PSC-MPCs plated onto LM411-E8 were relatively homogenous 
and followed an aligned transition from day 5 to day 7. On the other hand, those on Matrigel were relatively heter-
ogeneous, though a small subset of cells kept pace with those on LM411-E8 (Fig. 4b and Supplementary Fig. 10a). 
Overall, these results suggest that LM411-E8 facilitated uniform endothelial differentiation.
We next looked for the pathways contributing to endothelial differentiation in our culture. Gene set enrich-
ment analysis (GSEA) on each stage compared to undifferentiated stage A revealed the highly significantly 
up-represented pathways (FDR < 0.25, p < 0.0075) along the orderly differentiation (Fig. 4d and Supplementary 
Table 1). As shown in Fig. 4d, GSEA indicated that our culture successfully transform initial differentiation cells 
(Stage B; oxidative phosphorylation was elevated from pluripotent stage, compatible to previous reports20,21) into 
endothelial stages (Stage C to F). Interestingly, expanded enrichment maps (Fig. 4e, Supplementary Fig. 10b,c) 
figured out the close relationships between cytoskeleton-related Rho pathway and proliferation-related pathways 
during differentiation, especially in earlier endothelial (D and E) stages. Moreover, additional GSEA analysis 
revealed that Rho pathway is significantly enriched in cells on LM411-E8 than those on Matrigel in stage D and 
E, suggesting the function of LM411-E8 in stimulating proliferation of early stage endothelial progenitors via 
Rho pathway (Fig. 4f,g, Supplementary Table 2). Indeed, though expression of Rho itself was not upregulated, 
its’ activated form in PSC-EPCs show the clear increase on LM411-E8 (Fig. 5a), and chemical inhibition of the 
Rho-GTPase pathway drastically decreased the yield of PSC-EPCs (Fig. 5b) while maintaining the high purity 
(Fig. 5c). Considering that Rho signaling pathway is activated downstream to VEGF as well as various adhesion 
molecules including integrins22,23, these data highlight the important role of the Rho signaling pathway in achiev-
ing a higher endothelial yield under LM411-E8 and VEGF co-existing conditions.
Modification of initial mesodermal induction improved the efficiency of endothelial differen-
tiation. Although our differentiation system produces PSC-EPCs with high purity, the yield of PSC-EPCs 
is not satisfactory (see Fig. 2c). We considered that this might be because the number of PSC-MPCs adapted to 
www.nature.com/scientificreports/
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LM411-E8-guided differentiation system is still low. Therefore, to improve the yield of PSC-EPCs, we tried to 
modify the condition of initial differentiation into PSC-MPCs. Since endogenous activation of the Wnt-β -catenin 
pathway potentiates PSC differentiation towards the primitive streak and mesoderm24–26, we used CHIR99021, 
a potent inhibitor of GSK3β 27, to activate the Wnt-β -catenin pathway during initial differentiation. Additionally, 
we adopted a perfectly chemically-defined medium and recombinant LM511-E8 coating during initial differen-
tiation that is applicable to future regenerative medicine (Fig. 6a). This modified defined system maintained the 
same level of purity without cell sorting (Fig. 6b) but drastically increased the yield of PSC-EPCs, producing 10 
to 15 PSC-EPCs from one PSC (Fig. 6c). The modified protocol increased the growth rate in initial differentiation 
(Fig. 6d). These findings were compatible with the results of a quantitative expression assay, in which the Wnt 
pathway genes leading to cell cycle activation were up-regulated in PSC-MPCs under defined condition compared 
to both undifferentiated PSCs and PSC-MPCs under original undefined condition (Supplementary Fig. 11a,b, 
Supplementary Tables 3 and 4). The expansion rate of PSC-EPCs from PSC-MPCs was also increased in the 
defined system (Fig. 6e). The tube formation assay and LDL-uptake assay verified that the PSC-ECs in this system 
were functional (Fig. 6f,g). Indeed, the representative genes deeply associated with the endothelial function, such 
as vWF, eNOS and PECAM1, were up-regulated in PSC-EPCs (Fig. 6h). Furthermore, the expression of ICAM-1, 
a leukocyte adhesion molecule, was up-regulated by TNF-α stimulation (Fig. 6i). Importantly, LM411-E8 still 
showed significantly higher purity of PSC-EPCs than LM511-E8 (Fig. 6j). This finding supported the importance 
of guiding function by LM411-E8 for mesodermal progenitor cells, even in the Wnt-activated condition. Finally, 
we confirmed that the PSC-ECs could give rise to functional blood vessels in vivo. In the Matrigel plug assay, the 
transplanted PSC-EPCs successfully presented with vascularization perfused with mouse blood, verifying the 
functional activity of PSC-EPCs plated on LM411-E8 in vivo (Fig. 6k).
Discussion
Here we found that matrix switching onto LM411 and its C-terminal short fragments efficiently guides 
PSC-MPCs towards endothelial lineage. Our results highlight the importance of signal transduction through 
cell-matrix interaction for the fate decision of endothelial progenitor cells.
Figure 3. Effects of sequential switching of matrices during endothelial differentiation. (a) Schematic 
process of the double-switching assay. Day 3 cells were dissociated at the single-cell level and plated onto 
LM411-E8-coated plates. After 30 minutes of incubation at 37 °C, adherent cells were replated onto Matrigel, 
LM511-E8 and LM411-E8 and cultured with VEGF stimulation for four days. (b) Percentage of PSC-EPCs 
(KhES-1) differentiated from LM411-E8-selected mesodermal progenitors on Matrigel, LM511-E8 or 
LM411-E8 for four days. Data are presented as the mean ± SEM (n = 3) and were statistically analyzed using 
Student’s t-test. Representative results of at least two independent experiments are shown.
www.nature.com/scientificreports/
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Figure 4. Single-cell RNA-seq analysis during endothelial differentiation. (a) Sampling time points for 
single-cell RNA-seq. (b) Cell heterogeneity in the process of differentiation on LM411-E8 or Matrigel evaluated 
using principal component analysis based on single-cell RNA-seq data (KhES-1). Each cell was classified into 
6 stages (A–F). (c) Expression of undifferentiated cell marker ZFP42, mesodermal marker KDR, endothelial 
marker CDH5 and PECAM1 during differentiation. RPKM value of each gene was shown. (d) Gene set 
enrichment analysis (GSEA) following the orderly differentiation. Data sets of samples at stage B to F were 
independently compared to Stage A by GSEA. Genes with RPKM > 0 in at least one sample were applied to the 
analysis. Gene sets of significantly (FDR < 0.25, p < 0.0075) up-represented pathways at each stage in Hallmark 
(upper field) and BioCarta (lower field) were shown (size-filtered by 12–500). (e) An expanded enrichment 
map showing the relationship among gene sets up-represented at stage D. (f) Gene sets enriched in cells on 
Matrigel or LM411-E8. Data sets of samples at stage C to F were independently analyzed by GSEA. Genes with 
RPKM > 0 in at least one sample were applied to the analysis. Gene sets of significantly (FDR < 0.25, p < 0.05) 
up-represented pathways in BioCarta (size-filtered by 12–500) were shown. No pathway was significantly up-
represented at stage F. (g) A representative result of GSEA of day 5 cells differentiated on Matrigel or LM411-E8 
(KhES-1).
www.nature.com/scientificreports/
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LM411-coating yielded PSC-EPCs at higher purity compared to Matrigel and the other laminin matrix 
LM511. The part of these results may be associated with the specific binding spectrum of LM411 to integrin 
family proteins. One possibility is that the narrower binding spectrum of LM411 may increase the apparent 
specification efficacy by excluding the deviant population at initial adhesion. As shown in the binding assay 
using specific blocking antibodies to integrin (Supplementary Fig. 6b), adhesion of PSC-MPCs onto LM411-E8 
is exclusively dependent on integrin α 6β 1. Undesirable binding of LM511 to α 3β 1 and α 7β 1 in addition to α 6β 18  
may hold non-committed progenitors on the matrix. The other possibility is that integrin signaling other than 
α6β1 during differentiation hamper the commitment of PSC-MPCs into endothelial lineage. While integrin α 6β 1 
facilitates endothelial commitment through activation of Etv2, integrin α 3β 1 inhibits this pathway28. Since both 
LM111, a major component of Matrigel, and LM511 bind integrin α 3β 1 in addition to α 6β 1, these matrices might 
transduce conflicting signals to the progenitor cells, thereby reducing their specific commitment. The results of 
double-switching assay (Fig. 3a,b) support this possibility, as PSC-MPCs selected on LM411 did not differentiate 
into endothelial lineage efficiently on subsequent culture on LM511 or Matrigel. RNA expression analysis pro-
vided us interesting suggestions about intracellular functions responsible for present results. Previous studies 
have pointed out Rho family proteins as an important mediator of endothelial cell functions such as angiogenesis 
and stabilization. Especially, recent studies showed that RhoA mediates VE-cadherin expression and localization, 
which in turn negatively regulate angiogenesis by blocking VEGF signal as homeostatic mechanism. Present 
study may suggest the specific role of LM411-integrin α 6β 1 axis for supporting continual signal transduction in 
specific situation, e.g. embryonic vasculogenesis. However, further investigation will be needed since the possi-
bility that unknown off-target binding to LM411 required for efficient endothelial differentiation still remains.
The sequential switch from LM511-E8 to LM411-E8 in chemically defined medium successfully provided a 
novel defined system for inducing endothelial cells from PSCs, with more than 95% purity, without cell sorting: 
this rate is more efficient than that described in previous reports with a purity of 40%12, 55%29 and 55.5%30. 
The yield of PSC-EPCs per single PSC was approximately 10 to 15, which is also larger than most previous 
reports31. Although the yield in our system remains unsatisfactory, the possibility of combining our protocol with 
the scalable expansion of endothelial progenitor cells11 should be taken into account to facilitate future clinical 
applications.
In conclusion, the present study demonstrated the concept of matrix switching for the field of in vitro directed 
differentiation culture. In addition to the endothelial lineage, recent studies have reported LM511-E832 and 
laminin 11133,34 to be useful matrix components for delivering midbrain dopaminergic neurons and hepatocytes, 
respectively. We therefore propose that sequential switching of defined ECMs depending on the lineage and stage 
of cells is a reasonable strategy for establishing efficient differentiation systems.
Methods
Study approval. All experimental protocols were carried out in accordance with the relevant guidelines 
and approved by the relevant committees. The use of human embryonic stem cells (ESCs) was approved by the 
Ministry of Education Culture, Sports, Science and Technology (MEXT) of Japan. The use of human iPSCs was 
approved by the Ethics Committee of Kyoto University, and informed consent was obtained in accordance with 
the Declaration of Helsinki. The study plan for recombinant DNA research was approved by the Recombinant 
DNA Experiments Safety Committee of Kyoto University. The experimental protocol was approved by the Animal 
Research Committee of the Center for iPS Cell Research and Application, Kyoto University. Animal care was 
provided by the Institute of Laboratory Animals of the Center for iPS Cell Research and Application, Kyoto 
University.
Antibodies. Anti-human KDR antibodies (BioLegend), anti-human CD34 antibodies (Beckman coul-
ter), anti-human VE-cadherin antibodies (eBioscience), sheep anti-human CD31 antibodies (R&D systems), 
FITC-conjugated anti-sheep IgG antibodies (Jackson ImmunoResearch), mouse anti-human nuclei antibodies 
(Millipore), Cy3-conjugated anti-mouse IgG antibodies (Jackson ImmunoResearch), Alexa-Fluor 647-labelled rat 
Figure 5. Activation of Rho pathway in PSC-EPCs on LM411-E8. (a) Evaluation of Rho activation using a 
pull-down assay in the lysates of day 5 cells differentiated on Matrigel (left lane) and LM411-E8 (right lane) 
(KhES-1). The chemiluminescence intensity ratios of active to total Rho were shown below gel images. (b,c) 
Cell number (b) and percentage (c) of PSC-EPCs treated with Rho inhibitor I during differentiation from day 3 
(KhES-1). Data are presented as the mean ± SEM (n = 3) and were statistically analyzed using Student’s t-test. 
Representative results of at least two independent experiments are shown.
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Figure 6. Improvement of differentiation efficiency. (a) Schematic process of the modified differentiation 
system via activation of the canonical Wnt signaling pathway. (b) Representative flow cytometry plots of the 
day 6 cell population (KhES-1). (c) Efficiency of endothelial differentiation in the modified system compared 
to the unmodified system. The ordinates indicate the number of PSC-EPCs per starting PSC number. Data 
are presented as the mean ± SEM (n = 3) and were statistically analyzed using Student’s t-test. Representative 
results of at least three independent experiments are shown. (d) The cell numbers on day 3 (undefined system) 
and day 2 (defined system), normalized by starting PSC numbers. The data were analyzed using Student’s t-test, 
n = 3. (e) CD34+VE-cadherin+ cell numbers at day 6. Cell numbers were normalized by plated cell numbers on 
LM411-E8. The data were analyzed using Student’s t-test, n = 3. (f) A tube formation assay of PSC-ECs. Scale 
bars: 200 μ m. (g) Ac-LDL-uptake and CD31 expression of PSC-ECs. Scale bar: 10 μ m. (h) Expression of vWF, 
eNOS and PECAM1 in PSC-EPCs compared to undifferentiated (day 0) cells. The RQ values were calculated 
via the Δ Δ Ct-method using GAPDH on day 0 as an internal control. (i) ICAM-1 expression in PSC-ECs 
stimulated with 10 ng/mL TNF-α for 18 hours. (j) The proportion of CD34+VE-Cadherin+ cells on LM411-E8 
or LM511-E8. Day 2 cells were plated cultured for four days. The data were analyzed using Student’s t-test, n = 3. 
(k) Immunofluorescence images of Matrigel-plug sections. PSC-EPCs (KhES-1) generated according to the 
above method were suspended in Matrigel and subcutaneously transplanted to NOG mice. Human endothelial 
cells (positive for HuNu and CD31) can be seen surrounding murine erythrocytes (positive for TER-119). Scale 
bars: 5 μ m.
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anti-mouse TER-119 antibodies (BioLegend), rat anti-human CD49f antibodies (GoH3, BD), anti-human CD29 
antibodies (AIIB2; developed by Caroline H. Damsky and obtained from Developmental Studies Hybridoma 
Bank) were used in this study. Rabbit polyclonal antibody against ACID/BASE coiled-coil peptides was produced 
by immunizing with ACID/BASE coiled-coil peptides as an immunogen. HRP-conjugated streptavidin was pur-
chased from Thermo Scientific (Rockford, IL).
Reagents. The following reagents were obtained from the indicated manufacturers: bFGF (Wako), 
4% paraformaldehyde (Wako), crystal violet (Wako), ES medium (ReproCELL), mTeSR1 (STEMCELL 
TECHNOLOGIES), trypsin (Life technologies), collagenase IV (Life technologies), KSR (Life technologies), 
TrypLE Express (Life technologies), Stempro34 SFM (Life technologies), DiI-Ac-LDL (Life technologies), 
Endothelial Serum-Free Medium (Life technologies), Laemmli buffer (Bio-Rad), LM411 (Biolamina), LM511 
(Biolamina), Matrigel (BD), GFR-Matrigel (BD), Type IV collagen (BD), Cytofix (BD), Perm/Wash (BD), 
Fibronectin (Millipore), LM511-E8 fragment (Nippi), BMP4 (R&D systems), VEGF (R&D systems), RNeasy kit 
(QIAGEN), bovine serum albumin (BSA, sigma), DMEM/F12 (sigma), sodium dodecyl sulfate (SDS, Nacalai 
tesque) and CaCl2 (Nacalai tesque).
Cell lines. The human ES cell line KhES-1 was kindly provided by Dr. Hirofumi Suemori (Institute for 
Frontier Medical Sciences, Kyoto University, Kyoto, Japan). The human iPS cell lines 253G4 and 409B2 were 
kindly provided by Dr. Shinya Yamanaka (Center for iPS Cell Research Application, Kyoto University, Kyoto, 
Japan). The control iPSC clone 223Q5 was named W1 in a previous report35.
Maintenance of human pluripotent stem cells (PSCs). PSCs were maintained on SNL feeder cells in 
ES medium supplemented with 5 ng/mL of bFGF. At passage, the cells were dispersed with CTK solution (0.25% 
trypsin, 0.1% collagenase IV, 20% KSR and 1 mM CaCl2) for 30 seconds at room temperature, and SNL feeder cells 
were removed as previously reported36.
Dish and plate coating. BD falcon non-coating tissue culture plates and dishes were used in this study. 
The following matrices were diluted with phosphate-buffered saline (PBS) (− ) and used for dish coating at the 
indicated concentrations unless otherwise described: LM411 (2 μ g/cm2), LM511 (2 μ g/cm2), GFR (growth factor 
reduced)-Matrigel (20 μ g/cm2), fibronectin (2 μ g/cm2), LM411-E8 (0.4 μ g/cm2) and LM511-E8 (0.4 μ g/cm2). Type 
IV collagen was diluted in 0.05 M HCl and used for coating at 10 μ g/cm2. The dishes and plates were coated for 
2 hours at room temperature and rinsed with PBS (− ) before cell plating.
Differentiation of PSC-EPCs. PSC clumps were plated onto GFR-Matrigel-coated plates at a density 
of 2 clumps/cm2 and cultured in mTeSR1. When the colonies grew to a diameter of 750 μ m, the medium was 
replaced with fresh mTeSR1 containing BMP4 (80 ng/mL). After three days, the cells were dissociated to the 
single-cell level using TrypLE Express for 20 minutes at 37 °C and subsequently plated onto a matrix-coated plate 
and cultured for an additional four days in Stempro34SFM (Life technologies) containing VEGF (80 ng/mL).
In the modified system, PSC clumps were plated onto LM511-E8-coated plates at a density of 5 clumps/cm2 
and cultured in mTeSR1. When individual colonies grew up to the diameter of 750 μ m, the medium was replaced 
with Essential 8 (Life technologies) containing CHIR99021 (4 μ M), BMP4 (80 ng/mL) and VEGF (80 ng/mL). 
After two days, the whole culture was dissociated, plated onto LM411-E8-coated plates and cultured for four days 
in Stempro34SFM containing VEGF (80 ng/mL).
Flow cytometric analysis. Flow cytometric analysis data were collected using LSRFortessa (BD) and sub-
sequently analyzed with the FlowJo software package (Treestar).
LDL-uptake assay and immunocytochemistry. Cells were reacted with Ac-LDL in Endothelial 
Serum-Free Medium (ESFM) for 5 hours at 37 °C in 5% CO2 and then washed with PBS (− ) twice, fixed with 
Cytofix for 5 minutes and permeabilized with Perm/Wash at room temperature for 30 minutes. The primary anti-
body reaction with sheep anti-human CD31 antibodies (1:10) was performed at 4 °C overnight, and the cells were 
then washed with Perm/Wash twice. The secondary antibody reaction with FITC-conjugated anti-sheep IgG anti-
bodies (1:100) was performed at room temperature for one hour. After washing with Perm/Wash, fluorescence 
imaging was performed using a FluoView FV10i confocal microscope (OLYMPUS).
Tube formation assay. The tube formation assay was performed as previously reported28. For gel preparation, 
50 μ L of Matrigel was dispensed into each well of a 96-well plate and incubated at 37 °C for 30 minutes. The cells were 
suspended in ESFM supplemented with 80 ng/mL of VEGF, seeded at a density of 4 × 104/well and cultured overnight. 
For measurement of the tube length and number of blanching points, the Image J software package (NIH) was used.
Matrigel plug assay. The Matrigel plug assay was performed according to a previous report with some 
modifications37. Briefly, 1 × 106 cells suspended in 100 μ L of GFR-Matrigel supplemented with bFGF (300 ng/mL) 
were subcutaneously injected into the back skin of immunodeficient NOG mice (approximately 6 weeks old)38. 
The Matrigel plugs were harvested 21 days after transplantation and subjected to immunofluorescent staining.
Immunohistochemistry. Matrigel block was fixed with 4% paraformaldehyde overnight at 4 °C, equilibrated 
in 20% sucrose/PBS (− ) overnight at 4 °C and frozen embedded into O.C.T. compound. The embedded block was 
sectioned at a thickness of 6 μ m and adsorbed onto glass slides. The slides were dried in air, fixed with Cytofix for 
5 minutes at room temperature and permeabilized with Perm/Wash for 30 minutes at room temperature.
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The primary antibody reaction was carried out in Perm/Wash for 2 hours at room temperature using sheep 
anti-human CD31 antibodies (1:10), mouse anti-human nuclei antibodies (1:100) and Alexa-Fluor 647-labelled 
rat anti-mouse TER-119 antibodies (1:10). After washing with Perm/Wash twice, the secondary antibody reaction 
was carried out in Perm/Wash for 1 hour at room temperature using FITC-conjugated anti-sheep IgG antibodies 
(1:100) and Cy3-conjugated anti-mouse IgG antibodies (1:100). Images were obtained with a FluoView FV10i 
confocal microscope (OLYMPUS).
RNA extraction and real-time quantitative RT-PCR analysis. RNA samples were first prepared 
by silica gel membrane-based spin-columns (RNeasy -Kit; Qiagen, Valencia, CA, USA) in accordance with the 
manufacturer’s instructions. RNAs were then subjected to an RT reaction followed by cDNA amplification in 
accordance with the previously reported method39 with minimal modification. For targeted detection of four 
genes (vWF, eNOS, PECAM1 and GAPDH) and pathway-focused profiling (PrimerArray® Wnt signaling path-
way [#PH010] and PrimerArray® cell-cycle [#PH002], TaKaRa), quantitative RT-PCR experiments were per-
formed with a StepOnePlus™ Real-Time PCR System (Applied Biosystems) using a SYBR Premix Ex Taq II kit 
(#RR820S, TaKaRa), in accordance with the manufacturer’s instructions. Quantitative assessment of the expres-
sion was performed using the standard Δ CT method applying GAPDH as a single internal control (targeted 
detection), or a combination of GUSB, HPRT1, PGK1, ACTB, GAPDH, TBP, B2M and PPIA for multiple refer-
ences (PrimerArray).
The oligonucleotide primers for targeted detections were as follows: human vWF, 5′ -gaa atg tgt cag gag cga 
tg-3′ and 5′ -atc cag gag ctg tcc ctc a-3′ ; human eNOS, 5′ -gct gaa gga tgg ctg gac-3′ and 5′ -ttg gca tct tcg cat gtc-3′ ; 
human PECAM1, 5′ -gca aca cag tcc aga tag tcg t-3′ and 5′ -gac ctc aaa ctg ggc atc at-3′ ; human GAPDH, 5′ -agc cac 
atc gct cag aca c-3′ and 5′ -gcc caa tac gac caa atc c-3′ .
KEGG pathway mapping. Gene lists filtered by significant increases (p < 0.05, D00 vs. MPC) or two-fold 
differences (V2D03 vs. V3D02) were mapped to the human Wnt signaling pathway (KEGG hsa04310) in the 
KEGG database (http://www.genome.jp/kegg/).
RNA sequencing. Total RNA was extracted using the RNeasy kit as described in previous subsection, and 
the quality was tested with Bioanalyzer (Agilent). Ribosomal RNA was depleted by RiboZero Gold (Epicentre). 
RNA libraries were prepared with the Illumina TruSeq Stranded Total RNA Sample Prep kit and sequenced in 
the 100 cycle Single-Read mode of HiSeq2500 (Illumina). All sequence reads were extracted in FASTQ format 
using BCL2FASTQ Conversion Software 1.8.4 in the CASAVA 1.8.2 pipeline and mapped to hg19 reference genes, 
downloaded on 10th December, 2012, using TopHat v2.0.8b40 and quantified by RPKM for Genes41, downloaded 
on 19th October, 2012. Gene Ontology analysis was done using David v6.742. Total RNA samples were applied to 
RNA sequencing, and the data were analyzed using the Gene Spring software package.
Single-cell RNA sequencing. Cells were dispersed with TrypLE Express for 20 minutes at 37 °C. Single cells 
were sorted using FACS Aria II and dropped into 96-well plates filled with 10 μ L of Reaction buffer of SMARTer 
Ultra Low Input RNA – HV kit (Clontech), followed by cDNA synthesis and amplification according to the man-
ufacturer’s instruction. Sequencing libraries were constructed using Nextera XT DNA Sample Prep kit (Illumina). 
The libraries were sequenced and all sequence reads were extracted, mapped and quantified as above.
Gene Set Enrichment Analysis (GSEA). GSEA (http://software.broadinstitute.org/gsea/index.jsp) was 
used to estimate biological signatures. Data sets filtered by the criterion requiring RPKM > 0 in at least one sam-
ple were applied for each analysis with Molecular Signatures Database v5.1 (Hallmark and BioCarta gene sets, 
size-filters set at 12–500) using gene-set permutation. Networks were visualized by Cytoscape (http://www.cytos-
cape.org) (P-value Cutoff 0.05, FDR Q-value Cutoff 0.25 and Overlap Coefficient Cutoff 0.01 were used).
GSE accession number. RNA-seq datasets deposited in the GEO database can be accessed with the GEO 
accession number GSE85784.
Cell adhesion assay. The cell adhesion assay was performed as previously reported10. Ninety-six-well plates 
coated with matrices were blocked with 1% BSA in DMEM/F12 for 1 hour at room temperature. The cells were 
suspended in DMEM/F12 containing 0.1% BSA and plated onto coated wells. After 30 minutes of incubation, 
non-adherent cells were removed via pipetting with DMEM/F12 twice. The remaining adherent cells were fixed 
with 10% formaldehyde for 15 minutes at room temperature and post-fixed with 100% ethanol for 5 minutes at 
room temperature. The fixed cells were then stained with 0.4% crystal violet in methanol (100%) for 5 minutes at 
room temperature. After washing extensively with deionized water, the remaining crystal violet in the cells was 
eluted with 1% SDS and quantified by measuring the optical density at 570 nm using a multi-well plate reader. For 
the functional inhibition assay, cells were pre-incubated with neutralizing antibodies in DMEM/F12 containing 
0.1% BSA for 30 minutes on ice before plating.
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